Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis

BACKGROUND: Zoledronic acid (ZOL) is widely used for treatment of glucocorticoid-induced osteoporosis. The most common adverse effects of ZOL treatment are post-dose symptoms. ZOL-induced hepatotoxicity has very rarely been reported. CASE REPORT: Here, we described a 50-year-old Chinese woman who ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yan, Fu, Yong, Xing, Xiao-ping, Li, Mei, Wang, Ou, Xia, Wei-bo, Meng, Xun-wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546306/
https://www.ncbi.nlm.nih.gov/pubmed/26297149
http://dx.doi.org/10.1186/s40001-015-0161-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546306/
https://www.ncbi.nlm.nih.gov/pubmed/26297149
http://dx.doi.org/10.1186/s40001-015-0161-1

Ejemplares similares